Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
Loadsmart is a next-gen freight technology platform and 4PL that lower costs, increase efficiency, and digitize transportation for Shippers.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
IntelyCare is revolutionizing healthcare staffing, scheduling, and training by offering an enterprise workforce management platform.
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.
Graphite Bio is a next-generation gene editing company that is driven to apply our breakthrough technology.
DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.
Flame Biosciences is a clinical-stage company focused on therapies for cancer and other inflammatory diseases.
Rain Oncology is a operator of a clinical stage biotechnology company.
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
Janus Henderson Investors has invested in 229 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Therapeutics, Medical, Health Care, Pharmaceutical. The firm invests across 15 different industry categories.
Among tracked funding rounds, Graphite Bio received $150.7M in a Series B round. Janus Henderson Investors's total known invested capital is $34.7B.
Janus Henderson Investors's average investment size is $151.4M across its portfolio of 229 companies.
Recent Janus Henderson Investors portfolio additions include Synthekine, Loadsmart, Chinook Therapeutics, IntelyCare, Magenta Therapeutics. These companies were founded in 2020 or later.